Funding Agency

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research and Development Contracts (N01)
Project #
N01AI065315-002
Application #
2467013
Study Section
Project Start
1996-09-30
Project End
2001-09-29
Budget Start
1997-03-03
Budget End
1997-09-29
Support Year
Fiscal Year
1997
Total Cost
Indirect Cost

  Institution

Name
University of Massachusetts Medical School Worcester
Department
Type
Schools of Medicine
DUNS #
660735098
City
Worcester
State
MA
Country
United States
Zip Code
01655

  Publications

Roberts, Anjeanette; Thomas, William D; Guarner, Jeannette et al. (2006) Therapy with a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody reduces disease severity and viral burden in golden Syrian hamsters. J Infect Dis 193:685-92
Greenough, Thomas C; Babcock, Gregory J; Roberts, Anjeanette et al. (2005) Development and characterization of a severe acute respiratory syndrome-associated coronavirus-neutralizing human monoclonal antibody that provides effective immunoprophylaxis in mice. J Infect Dis 191:507-14
Greenough, Thomas C; Carville, Angela; Coderre, James et al. (2005) Pneumonitis and multi-organ system disease in common marmosets (Callithrix jacchus) infected with the severe acute respiratory syndrome-associated coronavirus. Am J Pathol 167:455-63
Babcock, Gregory J; Esshaki, Diana J; Thomas Jr, William D et al. (2004) Amino acids 270 to 510 of the severe acute respiratory syndrome coronavirus spike protein are required for interaction with receptor. J Virol 78:4552-60
Jeffers, Scott A; Tusell, Sonia M; Gillim-Ross, Laura et al. (2004) CD209L (L-SIGN) is a receptor for severe acute respiratory syndrome coronavirus. Proc Natl Acad Sci U S A 101:15748-53
Carlton, J M; Yowell, C A; Sturrock, K A et al. (2001) Biomagnetic separation of contaminating host leukocytes from plasmodium-infected erythrocytes. Exp Parasitol 97:111-4